Tributary Capital Management Has Cut Its Columbia Banking System (COLB) Holding; KemPharm, Inc. (KMPH) Had 5 Analysts Last Week

May 15, 2018 - By Marie Mckinney

KemPharm, Inc. (NASDAQ:KMPH) Logo

Among 5 analysts covering KemPharm (NASDAQ:KMPH), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. KemPharm had 20 analyst reports since August 14, 2015 according to SRatingsIntel. Oppenheimer maintained KemPharm, Inc. (NASDAQ:KMPH) on Sunday, February 25 with “Buy” rating. The stock has “Buy” rating by Canaccord Genuity on Monday, September 11. The rating was maintained by Oppenheimer on Wednesday, June 28 with “Buy”. The stock of KemPharm, Inc. (NASDAQ:KMPH) has “Buy” rating given on Friday, February 23 by Canaccord Genuity. As per Monday, April 2, the company rating was maintained by Roth Capital. The rating was maintained by RBC Capital Markets with “Outperform” on Friday, May 6. The firm earned “Buy” rating on Tuesday, January 16 by RBC Capital Markets. The stock of KemPharm, Inc. (NASDAQ:KMPH) earned “Buy” rating by Oppenheimer on Monday, April 2. The stock has “Buy” rating by Oppenheimer on Thursday, August 10. The firm has “Outperform” rating given on Friday, August 14 by RBC Capital Markets. See KemPharm, Inc. (NASDAQ:KMPH) latest ratings:

02/04/2018 Broker: Roth Capital Rating: Buy New Target: $9.5000 Maintain
02/04/2018 Broker: Oppenheimer Rating: Buy New Target: $13.0000 Maintain
26/02/2018 Broker: Canaccord Genuity Old Rating: Buy New Rating: Buy Old Target: $7 New Target: $11 Maintain
25/02/2018 Broker: Oppenheimer Rating: Buy New Target: $13.0 Maintain
23/02/2018 Broker: Canaccord Genuity Rating: Buy New Target: $11.0 Maintain
16/01/2018 Broker: RBC Capital Markets Rating: Buy New Target: $9.0 Maintain

Tributary Capital Management Llc decreased Columbia Banking System Inc (COLB) stake by 2.56% reported in 2017Q4 SEC filing. Tributary Capital Management Llc sold 8,112 shares as Columbia Banking System Inc (COLB)’s stock declined 6.99%. The Tributary Capital Management Llc holds 308,450 shares with $13.40M value, down from 316,562 last quarter. Columbia Banking System Inc now has $3.06B valuation. The stock decreased 0.10% or $0.04 during the last trading session, reaching $41.79. About 211,144 shares traded. Columbia Banking System, Inc. (NASDAQ:COLB) has risen 9.90% since May 15, 2017 and is uptrending. It has underperformed by 1.65% the S&P500.

It closed at $5.9 lastly. It is down 82.56% since May 15, 2017 and is uptrending. It has outperformed by 71.01% the S&P500.

KemPharm, Inc., a clinical-stage specialty pharmaceutical company, discovers and develops new proprietary prodrugs in the United States. The company has market cap of $89.12 million. The Company’s lead product candidates are KP415, an extended release d-threo-methylphenidate product candidate for the treatment of ADHD; and KP201/IR, an IR formulation of KP201, a prodrug of hydrocodone and acetaminophen for the treatment of acute pain. It currently has negative earnings. The firm is also involved in developing KP511/ER, a prodrug of hydromorphone for the management of pain; KP511/IR for the short duration management of acute pain; KP606/IR, an IR formulation of KP606, a prodrug of oxycodone for the management of moderate to severe pain; KP746, a prodrug of oxymorphone for the management of moderate to severe pain; and KP303, a prodrug of quetiapine for the treatment of central nervous system disorders.

More important recent KemPharm, Inc. (NASDAQ:KMPH) news were published by: Seekingalpha.com which released: “KemPharm: Patients Not Liking Their Drugs Is Great News” on May 14, 2018, also Globenewswire.com published article titled: “KemPharm, Inc. to Report First Quarter 2018 Results”, Seekingalpha.com published: “The Takeda-Shire Deal: Potential Impact On Neuroscience” on May 01, 2018. More interesting news about KemPharm, Inc. (NASDAQ:KMPH) was released by: Globenewswire.com and their article: “KemPharm Announces Positive, Topline Results from an Intravenous Human Abuse Potential Trial with KP415 Prodrug …” with publication date: May 10, 2018.

Since January 8, 2018, it had 4 insider buys, and 1 sale for $85,597 activity. $1,978 worth of stock was bought by Stein Clint on Monday, January 8. BARUFFI KUMI YAMAMOTO had bought 174 shares worth $6,374. McDonald Andy bought 132 shares worth $4,835. Shares for $2,784 were bought by Lawson David C on Monday, January 8.

More recent Columbia Banking System, Inc. (NASDAQ:COLB) news were published by: Streetinsider.com which released: “Columbia Banking System (COLB) Names Greg Sigrist as CFO” on May 03, 2018. Also Nasdaq.com published the news titled: “Research Report Identifies Signature Bank, Concert Pharmaceuticals, Easterly Government Properties, Hilltop …” on April 23, 2018. Prnewswire.com‘s news article titled: “Columbia Bank Promotes Brock Lakely To Chief Accounting Officer” with publication date: May 04, 2018 was also an interesting one.

Investors sentiment increased to 2.6 in Q4 2017. Its up 1.65, from 0.95 in 2017Q3. It increased, as 14 investors sold COLB shares while 38 reduced holdings. 44 funds opened positions while 91 raised stakes. 61.59 million shares or 13.33% more from 54.35 million shares in 2017Q3 were reported. Bsw Wealth holds 0.49% or 26,877 shares. 49,116 were accumulated by Asset Mgmt One. Public Employees Retirement Association Of Colorado has invested 0.17% in Columbia Banking System, Inc. (NASDAQ:COLB). 70,299 are owned by Amundi Pioneer Asset Mgmt. Washington Bank reported 0.04% of its portfolio in Columbia Banking System, Inc. (NASDAQ:COLB). 20,195 were accumulated by Millennium Management Lc. Madrona Services Limited Liability Company holds 0.51% or 13,830 shares. Invesco holds 0.01% of its portfolio in Columbia Banking System, Inc. (NASDAQ:COLB) for 408,125 shares. Assetmark stated it has 0% in Columbia Banking System, Inc. (NASDAQ:COLB). Point72 Asia (Hong Kong) Ltd has 17 shares. Deprince Race & Zollo stated it has 0.03% in Columbia Banking System, Inc. (NASDAQ:COLB). Amalgamated Savings Bank owns 10,265 shares or 0.01% of their US portfolio. Pnc Fin Services Gru Inc accumulated 1,729 shares or 0% of the stock. Northwestern Mutual Wealth Com has invested 0% in Columbia Banking System, Inc. (NASDAQ:COLB). First Republic Invest Mngmt Incorporated reported 0.01% of its portfolio in Columbia Banking System, Inc. (NASDAQ:COLB).

Among 6 analysts covering Columbia Banking System Inc. (NASDAQ:COLB), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. Columbia Banking System Inc. had 23 analyst reports since January 29, 2016 according to SRatingsIntel. As per Tuesday, January 30, the company rating was maintained by Piper Jaffray. The stock has “Buy” rating by Piper Jaffray on Tuesday, September 12. The rating was maintained by Keefe Bruyette & Woods with “Hold” on Monday, August 14. RBC Capital Markets maintained Columbia Banking System, Inc. (NASDAQ:COLB) on Thursday, January 25 with “Hold” rating. The stock has “Hold” rating by Sandler O’Neill on Friday, January 26. The rating was maintained by DA Davidson on Friday, April 27 with “Buy”. RBC Capital Markets maintained Columbia Banking System, Inc. (NASDAQ:COLB) on Thursday, September 7 with “Hold” rating. On Friday, September 15 the stock rating was maintained by Keefe Bruyette & Woods with “Hold”. Keefe Bruyette & Woods maintained Columbia Banking System, Inc. (NASDAQ:COLB) on Thursday, July 13 with “Hold” rating. The company was downgraded on Friday, April 29 by Piper Jaffray.

Columbia Banking System, Inc. (NASDAQ:COLB) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>